Skip to main content

Table 1 Clinical characteristics of kidney transplant patients, (n = 450)

From: Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis

Characteristics N (%)
Age at transplantation (years) 45 ± 13
 <60 377 (83.8)
 ≥ 60 73 (16.2)
Gender  
 Male 293 (65.1)
 Female 157 (34.9
Follow up time (months); median (range) 38 (2-71)
Type of donor  
 Live related donor 192 (42.7)
 Diseased donor 258 (57.3)
Number of transplant  
 First 436 (96.9)
 Second 11 (2.4)
 Third 3 (0.7)
Induction agent  
 Daclizumab 237 (52.7)
 Basiliximab 176 (39.1)
 Anti-thymocyte globulin 23 (5.1)
 None 14 (3.1)
Death at last follow-up  
 No 439 (97.6)
 Yes 11 (2.4)
Graft functionality at death  
 Unknown 1 (9.1)
 Graft in function 8 (72.7)
 Graft not in function 2 (18.2)
Rejection  
 No 417 (92.6)
 Yes 33 (7.4)
Pre-transplant VZV disease  
 No 51 (11.3)
 Yes 201 (44.7)
 Unknown 198 (44)